Published in Blood Weekly, September 29th, 2005
Patients with VTE "are susceptible to recurrent events, but whether prolonging anticoagulation is warranted in patients with VTE remains controversial," according to physicians in New York, who conducted a study to "quantify the risks and benefits of extending the duration of anticoagulation in patients with VTE."
"PubMed, EMBase Pharmacology, the Cochrane database, clinical trial Web sites, and a hand search of reference lists" were reviewed, D. Ost and coauthors at the North Shore University Hospital explained. "Included studies were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.